Label 150mg (Bupropion 150mg 30 Tab Container Label)
Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 68001-520
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 68001-520). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label 300mg Count 30 (Bupropion 300mg 30 Tab Container Label)
This is a description for a medication containing 300 mg bupropion hydrochloride USP. The tablets are extended-release and must be taken once daily as directed by a physician. The usual dosage can be found on the prescribing information. The tablets must be stored at 25°C (77°F) and protected from light. They should be preserved in well-closed containers. The medication should not be used in combination with ZYBAN® or any other medicines containing bupropion HCI. The enclosed medication guide should be dispensed to each patient. The manufacturer is Intas Pharmaceuticals Limited in Ahmedabad, India. The lot and EXP data matrix is provided.*
Wellbutrin Chemical Structure (Bupropion Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
